Clinical Trials Directory

Trials / Completed

CompletedNCT06257901

A Co-designed Physical Activity Intervention in Fabry Disease

Co-design of a Physical Activity and Sedentary Behaviour Intervention for Adults with Fabry Disease

Status
Completed
Phase
Study type
Observational
Enrollment
41 (actual)
Sponsor
Brunel University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Currently, treatments for Fabry disease are pharmacological and predominantly focus on the physical symptoms of the disease. In the general population and individuals with disabilities, increasing physical activity levels and reducing sedentary time can be an effective, non-pharmacological treatment to improve mental health and quality of life. Such interventions have not yet been developed or evaluated in people with Fabry disease. The aim of this study is to co-design a physical activity and sedentary behaviour intervention tailored to the needs of adults with Fabry disease. The study will seek to gain the expertise of adults with Fabry disease, specialist stakeholders (physicians, cardiologists and clinical nurse specialists) and lay specialist stakeholders (family and friends of adults with Fabry disease and members of staff and volunteers at the Society for Mucopolysaccharide Diseases). A range of views and experiences of physical activity and sedentary behaviour will be explored via focus groups (with individuals with Fabry disease and lay specialist stakeholders) and semi-structured interviews (with specialist stakeholders). The information gathered from the focus groups and interviews will then be utilised to inform participatory workshops (with individuals with Fabry disease) to test intervention concepts. Data from these activities will inform the design of a future intervention.

Conditions

Interventions

TypeNameDescription
OTHERInterviews/Focus groups/Participatory workshopsQualitative study (no intervention delivered)

Timeline

Start date
2024-03-01
Primary completion
2024-09-30
Completion
2024-09-30
First posted
2024-02-14
Last updated
2025-02-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06257901. Inclusion in this directory is not an endorsement.